NCT00313599View on ClinicalTrials.gov

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Bladder CancerBrain and Central Nervous System TumorsBreast CancerEsophageal CancerExtragonadal Germ Cell TumorGastric CancerLung CancerOvarian CancerProstate Cancer
Interventions
DRUG

lapatinib

DRUG

paclitaxel

Trial Locations (1)

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT00313599 - Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter